Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
Go back to Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer| (NASDAQ: EWTX) | Delayed: 42.30 +3.47 (8.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.83 | 52 Week High | $ | |||
| Open | $38.97 | 52 Week Low | $ | |||
| Day High | $42.46 | P/E | N/A | |||
| Day Low | $38.62 | EPS | $ | |||
| Volume | 1,339,156 | |||||
